Mechanisms of cancer cell dormancy—another hallmark of cancer?

AC Yeh, S Ramaswamy - Cancer research, 2015 - AACR
Disease relapse in cancer patients many years after clinical remission, often referred to as
cancer dormancy, is well documented but remains an incompletely understood …

Quiescent cancer cells—a potential therapeutic target to overcome tumor resistance and relapse

E Lindell, L Zhong, X Zhang - International Journal of Molecular Sciences, 2023 - mdpi.com
Quiescent cancer cells (QCCs) are nonproliferating cells arrested in the G0 phase,
characterized by ki67low and p27high. QCCs avoid most chemotherapies, and some …

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency

X Sun, J Liu, C Xu, SC Tang… - Journal of cellular and …, 2016 - Wiley Online Library
The ability of the classic tumour‐suppressive let‐7 family to inhibit carcinogenesis, tumour
progression, recurrence and pluripotency of cancer stem cells has generated significant …

TGF-β family signaling pathways in cellular dormancy

C Prunier, D Baker, P Ten Dijke, L Ritsma - Trends in cancer, 2019 - cell.com
Individual cancer cells can switch, reversibly, to a non-proliferative dormant state, a process
characterized by two principal stages:(i) establishment and maintenance, and (ii) the …

Mechanisms governing metastatic dormancy in breast cancer

J Dittmer - Seminars in cancer biology, 2017 - Elsevier
Breast cancer is a systemic disease characterized by early dissemination of tumor cells to
distant organs. In this foreign environment, tumor cells may stay in a dormant state as single …

[HTML][HTML] Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

J Chen, Z Ding, S Li, S Liu, C Xiao, Z Li, B Zhang… - Theranostics, 2021 - ncbi.nlm.nih.gov
During the past decades, drugs targeting transforming growth factor-β (TGFβ) signaling have
received tremendous attention for late-stage cancer treatment since TGFβ signaling has …

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

AJ Wiecek, SJ Cutty, D Kornai, M Parreno-Centeno… - Genome Biology, 2023 - Springer
Background Therapy resistance in cancer is often driven by a subpopulation of cells that are
temporarily arrested in a non-proliferative G0 state, which is difficult to capture and whose …

NOTCH signaling regulates asymmetric cell fate of fast-and slow-cycling colon cancer–initiating cells

T Srinivasan, J Walters, P Bu, EB Than, KL Tung… - Cancer research, 2016 - AACR
Colorectal cancer cells with stem-like properties, referred to as colon cancer–initiating cells
(CCIC), have high tumorigenic potential. While CCIC can differentiate to promote cellular …

JARID1B enables transit between distinct states of the stem-like cell population in oral cancers

ND Facompre, KM Harmeyer, X Sole, S Kabraji… - Cancer research, 2016 - AACR
The degree of heterogeneity among cancer stem cells (CSC) remains ill-defined and may
hinder effective anti-CSC therapy. Evaluation of oral cancers for such heterogeneity …

The role of mitosis in generating fitness heterogeneity

JH Buss, LS Lenz, LC Pereira, D Torgo… - Journal of Cell …, 2023 - journals.biologists.com
Cancer cells have heterogeneous fitness, and this heterogeneity stems from genetic and
epigenetic sources. Here, we sought to assess the contribution of asymmetric mitosis (AM) …